Stage IV Cutaneous Melanoma AJCC v6 and v7 Active Not Recruiting Phase 2 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0091050 (Stage IV Cutaneous Melanoma AJCC v6 and v7)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02500576Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic MelanomaTreatment